14. Subsequent Events	9 Months Ended
Dec. 31, 2015
Subsequent Events [Abstract]
14. Subsequent Events	Management has evaluated events subsequent to December 31, 2015 through the date that the accompanying condensed consolidated financial statements were filed with the Securities and Exchange Commission for transactions and other events which may require adjustment of and/or disclosure in such financial statements. Termination of Exosome Sciences, Inc. Lease In January 2016, we exercised our 30 day notice to terminate the Exosome Sciences’ lease in New Jersey (see Note 13) as part of a consolidation of our laboratory operations in San Diego.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

No definition available.

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration